Upcoming events

Apr 2017

2017-04-01 00:00:00.000000
7-9 Apr 2017
PCR Tokyo Valves 2017

Tokyo

Japan

May 2017

2017-05-01 00:00:00.000000
16-19 May 2017
EuroPCR 2017

Paris

France

Real-world considerations for selecting antiplatelet therapy in high-risk ACS patients: putting evidence into clinical practice

This educational programme is accredited by EBAC for one hour of External CME credit - Programme supported by an unrestricted educational grant from ASTRAZENECA

Summary

play

Click here to watch the VIDEO

Learning Objectives

  • To appreciate new developments in ACS risk stratification and develop appropriate treatment strategies to improve outcomes for high-risk ACS patients
  • To understand the issues surrounding short- versus long-term antiplatelet therapy
  • To discuss best practices in antiplatelet therapy from both case-based and guidelines-based perspectives